RVP · Retractable Technologies Inc

$0.67 0.00 (-0.01%) At close · Jul 28

Market Cap

$20.06M

29.94M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$1,211,545	—	—	—	—	$10,500	$1,222,045
General Counsel		$400,000	—	—	—	—	$10,500	$410,500
John W. Fort III	CFO	$300,000	—	—	—	—	$9,992	$309,992
Kevin McGlinchey	Vice President of Domestic Sales Development	$275,000	$500	—	—	—	$16,953	$292,453
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$4,973	$203,879

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$1,178,295	—	—	—	—	$10,350	$1,188,645
General Counsel		$400,000	—	—	—	—	$10,350	$410,350
Michele M. Larios	Vice President,	$400,000	—	—	—	—	$10,350	$410,350
John W. Fort III	CFO	$300,000	—	—	—	—	$9,000	$309,000
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$4,973	$203,879
Lawrence G. Salerno	Board Member	$188,000	$500	—	—	—	$5,655	$194,155

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$1,139,550	—	—	—	—	$9,900	$1,149,450
Michele M. Larios	Vice President,	$400,000	—	—	—	—	$5,457	$405,457
General Counsel		$400,000	—	—	—	—	$5,457	$405,457
John W. Fort III	CFO	$300,000	—	—	—	—	$9,346	$309,346
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$500	—	—	—	$12,050	$210,956
Lawrence G. Salerno	Board Member	$188,000	$500	—	—	—	$7,587	$196,087

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$1,068,654	—	—	—	—	$9,150	$1,077,804
Michele M. Larios	Vice President,	$400,000	—	—	—	—	$5,538	$405,538
John W. Fort III	CFO	$300,000	—	—	—	—	$2,769	$302,769
Kathryn M. Duesman	Vice President of Clinical Affairs	$198,406	$327	—	—	—	$4,960	$203,693
Lawrence G. Salerno	Board Member	$188,000	$327	—	—	—	$5,423	$193,750

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$1,000,000	$300,000	—	$10,212,000	—	$5,800	$11,517,800
Michele M. Larios	Vice President,	$400,000	$100,000	—	$2,552,500	—	$1,346	$3,053,846
John W. Fort III	CFO	$300,000	$100,000	—	$1,021,000	—	$5,538	$1,426,538
Kathryn M. Duesman	Vice President of Clinical Affairs	$192,156	$124,767	—	—	—	$3,841	$320,764
Lawrence G. Salerno	Board Member	$179,667	$106,775	—	—	—	$3,511	$289,953

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$511,016	—	—	—	—	$5,700	$516,716
Michele M. Larios	General Counsel	$350,000	—	—	—	—	$1,015	$351,015
General Counsel		$350,000	—	—	—	—	$1,015	$351,015
Clinical Affairs	—	$180,912	$100,000	—	—	—	$3,608	$284,520
Kathryn M. Duesman	Vice President of Clinical Affairs	$180,912	$100,000	—	—	—	$3,608	$284,520
Lawrence G. Salerno	Board Member	$165,333	$100,000	—	—	—	$5,305	$270,638
John W. Fort III	CFO	$200,000	—	—	—	—	$4,000	$204,000
Russell B. Kuhlman	Vice President, Sales Development	$153,649	—	—	—	—	$3,062	$156,711

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$499,526	—	—	—	—	$5,600	$505,126
Michele M. Larios	General Counsel	$350,000	—	—	—	—	$2,962	$352,962
General Counsel		$350,000	—	—	—	—	$2,962	$352,962
John W. Fort III	CFO	$200,000	—	—	—	—	$923	$200,923
Global Health	—	$174,999	—	—	—	—	$3,493	$178,492
Kathryn M. Duesman	Vice President of Clinical Affairs	$174,999	—	—	—	—	$3,493	$178,492
Lawrence G. Salerno	Board Member	$148,722	—	—	—	—	$2,992	$151,714
Russell B. Kuhlman	Vice President, Sales Development	$148,728	—	—	—	—	$2,968	$151,696
Douglas W. Cowan	CFO	$105,879	—	—	—	—	$2,118	$107,997

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas J. Shaw	CEO	$490,247	—	—	—	—	$5,500	$495,747
Michele M. Larios	Vice President,	$350,000	—	—	—	—	$5,500	$355,500
Douglas W. Cowan	CFO	$290,000	—	—	—	—	$5,500	$295,500
Kathryn M. Duesman	Vice President of Clinical Affairs	$174,999	—	—	—	—	$3,359	$178,358
Russell B. Kuhlman	Vice President, Sales Development	$148,728	—	—	—	—	$2,857	$151,585

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michele M. Larios	Vice President,	$350,000	$250,000	—	—	—	$5,400	$605,400
Douglas W. Cowan	CFO	$290,000	$250,000	—	—	—	$4,908	$544,908
Thomas J. Shaw	CEO	$479,694	—	—	—	—	$5,400	$485,094
Kathryn M. Duesman	Board Member	$175,012	—	—	—	—	$3,493	$178,505
Russell B. Kuhlman	Vice President, Sales Development	$148,741	—	—	—	—	$2,968	$151,709

Key facts CIK 946563 CUSIP 76129W105 13F (30d) 4 filings 4 filers Visit website